Loss of NF1 drives ER+ breast cancer metastasis on two fronts
The findings suggest that loss of NF1 allows ER+ breast cancer cells to remodel their environment in ways that favor their survival and growth.
Read More
The findings suggest that loss of NF1 allows ER+ breast cancer cells to remodel their environment in ways that favor their survival and growth.
Read MoreCS18 is a candidate for further development as a drug that could become part of combination treatments to prevent or overcome cancer drug resistance.
Read MoreThis method is easily adaptable to other organs and can be used by researchers to develop their own cancer models.
Read MoreThe Baylor team is building the case for SRC-3 as a promising therapeutic target for next-generation cancer immunotherapy.
Read MoreThe Image this month shows a mechanism that mediates the formation of breast cancer cell clusters and promotes cancer metastasis.
Read MoreLearn more about the Baylor Medicine breast cancer surgery team and our multidisciplinary model.
Read MoreThe Causal Pivot accounts for genetic diversity within a disease and can be adapted to the clinic of tomorrow.
Read MoreSix Baylor College of Medicine faculty were honored this year with the Michael E. DeBakey M.D. Award for Excellence in Research for their outstanding published scientific contributions to clinical and basic science research over a three-year period.
Read MoreBeing able to predict the response of cancer to treatment by analyzing a tumor sample before therapy is given would significantly affect clinical outcomes
Read MoreDr. Anthony Costales offers five tips to help women of all ages prevent or reduce their risk of various cancers.
Read More